In short
Menopause, defined as 12 consecutive months without menstruation, marks the end of ovarian oestrogen production. At CLCC, care for menopause support follows a five-step structured assessment: Assess, Identify, Reduce, Restore, Continue, addressing the systemic contributors alongside standard medical treatment, rather than symptom management alone.
About This Condition
Menopause marks the beginning of a new hormonal environment, managing it well determines health outcomes for decades.
Menopause, defined as 12 consecutive months without menstruation, marks the end of ovarian oestrogen production. The post-menopausal period is characterised by sustained low oestrogen, which accelerates multiple physiological processes: bone resorption increases significantly, cardiovascular risk rises, central fat deposition accelerates, cognitive function changes, and vasomotor symptoms (hot flashes, night sweats) may continue for years beyond the final period.
CLCC menopause support addresses the key health domains affected by the post-menopausal hormonal environment: bone health through therapeutic nutritional correction and weight-bearing exercise; metabolic health through dietary structure and insulin sensitivity support; cardiovascular risk reduction through dietary and lifestyle correction; vasomotor symptom reduction through nutritional and phytoestrogen-based approaches; and cognitive support through metabolic and nutritional optimisation. This is long-term health management, not short-term symptom relief.
Symptoms
Common symptoms and presentations.
Persistent hot flashes and night sweats, occurring for months to years post-menopause
Sleep disruption from vasomotor symptoms
Accelerating weight gain, particularly central adiposity
Bone pain or known osteopenia / osteoporosis from post-menopausal bone loss
Vaginal dryness and discomfort
Urinary frequency or urgency from genitourinary syndrome of menopause
Cognitive changes, memory, concentration, word-finding
Mood changes, low mood or anxiety
Joint aching, more common post-menopause
Skin changes, dryness, reduced elasticity
Contributing Factors
What drives and sustains this condition.
Oestrogen deficiency
Sustained low oestrogen drives bone resorption acceleration, endothelial dysfunction, central fat deposition, and vasomotor instability. Supporting the systemic environment modulates the severity of these oestrogen-deficiency consequences.
Metabolic acceleration
Post-menopausal insulin resistance is significantly more pronounced than pre-menopausal, driven by oestrogen's role in insulin sensitivity. Dietary structure for metabolic protection is the most important post-menopausal lifestyle intervention for long-term cardiovascular and metabolic health.
Bone density decline
Post-menopausal bone loss continues at 1–2% per year without intervention. Therapeutic nutritional correction, vitamin D3, calcium, K2, magnesium, combined with weight-bearing exercise is the most effective non-pharmacological approach to preserving bone density.
Cardiovascular risk elevation
Post-menopausal loss of oestrogen's cardioprotective effects elevates LDL cholesterol, C-reactive protein, and endothelial dysfunction markers. Dietary and lifestyle correction directly addresses these risk factors.
The CLCC Method: All Five Steps
Assessment first. Then all five steps, applied specifically.
Full post-menopausal health assessment across all affected domains
Bone density, DEXA review or order. Metabolic panel, fasting insulin, HbA1c, lipid profile. Cardiovascular risk markers, CRP, homocysteine. Vitamin D, calcium, K2, magnesium. Hormonal profile for baseline. Vasomotor symptom severity and frequency. Cognitive function and mood assessed.
Identify which post-menopausal health domains carry the greatest immediate risk
Bone loss rate, metabolic profile, cardiovascular risk, and vasomotor symptom severity each require different primary intervention emphasis. The assessment identifies the priority domains for the initial phase of the care plan.
Coordinated bone, metabolic, cardiovascular, and symptom support
Therapeutic vitamin D3, calcium citrate, K2, and magnesium for bone health. Low-insulin dietary protocol for metabolic and cardiovascular protection. Phytoestrogen-rich dietary elements for vasomotor symptom support. Omega-3 for cardiovascular and cognitive support. Weight-bearing exercise structure.
Track bone density, metabolic markers, and cardiovascular risk at annual intervals
DEXA at 2-year intervals. Annual metabolic and cardiovascular panel. Vasomotor symptom frequency and severity tracked quarterly. Nutritional markers reviewed annually. Protocol adjusted as post-menopausal health evolves.
Long-term post-menopausal health management, decades, not months
Post-menopausal health management is a permanent life stage, not a temporary intervention. The Continue phase provides structured long-term monitoring and support, adjusting nutritional, metabolic, and lifestyle protocols as age-related changes require, and maintaining the comprehensive health management that protects against the long-term consequences of oestrogen deficiency.
FAQs
Common questions about care.
Is HRT appropriate for post-menopausal women?+
HRT is appropriate for many post-menopausal women, particularly for sustained vasomotor symptoms, accelerated bone loss, or significant quality-of-life impact. The decision involves individual cardiovascular and breast health risk assessment and is made with a specialist. CLCC care addresses the nutritional, metabolic, and lifestyle dimensions that complement HRT or that form the primary approach when HRT is not preferred or appropriate.
How long do hot flashes last after menopause?+
Vasomotor symptoms (hot flashes and night sweats) last an average of 7 years post-menopause for many women, and for some, significantly longer. Their frequency and severity are modulated by body weight, metabolic health, stress load, and dietary patterns, all of which are addressable through structured care.